U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Structurally Diverse
Created
by admin
on Sat Dec 16 18:20:49 UTC 2023
Edited
by admin
on Sat Dec 16 18:20:49 UTC 2023
Source Materials Class ORGANISM
Source Materials Type ALLOGENIC HUMAN
Source Materials State LIVE
Source Materials Parent
Part BLOOD
Fraction Name Peripheral blood mononuclear cells are obtained via apheresis from donors who are confirmed to be seropositive for the four target viruses (RSV, Influenza, PIV, hMPV)
Record UNII
EVQ94BW5G4
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Spunoleucel
USAN  
Official Name English
Allogeneic Multi-Virus Specific T Lymphocytes Targeting Respiratory Syncytial Virus (RSV), Influenza, Parainfluenza Virus (PIV), and Human Metapneumovirus (hMPV)
Common Name English
ALVR106 is a polyclonal (CD4+ and CD8+) virus-specific T cell product containing cells that are reactive against four viruses (RSV, Influenza, PIV, and hMPV). The cells are derived from peripheral blood mononuclear cells (PBMCs) from donors seropositive
Common Name English
ALVR106
Code English
ALVR106 is comprised of both CD8+ and CD4+ virus-specific T cells capable of recognizing actively replicating virus-infected cells, proliferating in response to antigenic stimulation and mediating antiviral effects including the production of cytokines a
Common Name English
ALVR106 is a novel virus-specific cell-based therapy to treat four respiratory viral infections that are a serious cause of morbidity and mortality in immunocompromised patients. ALVR106 is under development to treat four respiratory viral infections (re
Common Name English
SPUNOLEUCEL [USAN]
Common Name English
ALV-106
Code English
Code System Code Type Description
USAN
KL-230
Created by admin on Sat Dec 16 18:20:49 UTC 2023 , Edited by admin on Sat Dec 16 18:20:49 UTC 2023
PRIMARY
INN
12976
Created by admin on Sat Dec 16 18:20:49 UTC 2023 , Edited by admin on Sat Dec 16 18:20:49 UTC 2023
PRIMARY
FDA UNII
EVQ94BW5G4
Created by admin on Sat Dec 16 18:20:49 UTC 2023 , Edited by admin on Sat Dec 16 18:20:49 UTC 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY

Agent Modifications

Modification Process Modification Role Modification Type Amount Fragment Name Fragment ID
CULTURE EXPANSION INTERLEUKIN-7 HUMAN RECOMBINANT 418XB47Y71
CULTURE EXPANSION IL-4 HUMAN 4I7AHS3FPJ
CULTURE other UNSPECIFIED SUBSTANCE e06f5a80